Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-ENAD-35

ABSTRACT: HipSci Project - RNAseq of healthy volunteers

TISSUE(S): Skin, Blood

PROVIDER: E-ENAD-35 | ExpressionAtlas | 2020-07-10

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-ENAD-35-analysis-methods.tsv	Tabular
	E-ENAD-35-atlasExperimentSummary.Rdata	Rdata
	E-ENAD-35-coexpressions.tsv.gz	Tabular
	E-ENAD-35-configuration.xml	Xml
	E-ENAD-35-factors.xml	Xml

Items per page:

1 - 5 of 587

Similar Datasets

RNAseq analysis of blood from influenza infected patients and healthy controls

Project description:Gene expression changes in the blood was studied by RNAseq Results: Strong differential host reponse after infection with influenza virus compared to healthy controls project SIG_2020

2024-07-30 | GSE196350 | GEO

RNAseq analysis of blood from influenza infected patients and healthy controls SIG-2018

Project description:Gene expression changes in the blood was studied by RNAseq; project SIG-2018 Results: Strong differential host reponse after infection with influenza virus compared to healthy controls

2024-07-30 | GSE158592 | GEO

RNAseq analysis of blood from influenza infected patients and healthy controls-SIG2019

Project description:Gene expression changes in the blood was studied by RNAseq; project SIG-2019 Results: Strong differential host reponse after infection with influenza virus compared to healthy controls

2024-07-30 | GSE155635 | GEO

Healthy Start BabyBUMP RNASeq

Project description:Healthy Start BabyBUMP RNASeq

| PRJNA422647 | ENA

Healthy Start BabyBUMP RNASeq

Project description:Healthy Start BabyBUMP RNASeq

| PRJNA422648 | ENA

RNA-seq of human primary epithelial nasal cells infected with SARS-CoV-2 (20A clade) and treated with long chain inorganic polyphosphates (polyP120) against vehicle-(saline solution)- treated controls

Project description:Primary human nasal epithelial cells collected by nasal brushing of healthy donors (data deposited at: EVA- EMBL-EBI; project ID: PRJEB42411; analyses: ERZ1700617) were plated (3x105 cells) and infected with SARS-CoV-2 viral particles 20A (EPI_ISL_514432-S66; MOI, 0.03). After 24 hours, the infected cells were treated with 18.5 microMolar long chain inorganic polyphosphates (polyP120) or vehicle (saline solution) as the negative control for the treatment. After 36 hours, the cells were lysed, and their RNA were extracted for RNAseq.

2024-05-31 | E-MTAB-13363 | biostudies-arrayexpress

RNAseq analysis of blood from influenza infected patients and healthy controls, project SIG_2022

Project description:RNAseq analysis of blood from influenza infected patients and healthy controls, project SIG_2022

| PRJNA879439 | ENA

Project description:Elimäki Project RNASeq

| PRJNA547511 | ENA

MLD Project RNAseq

Project description:MLD Project RNAseq

| PRJNA603217 | ENA

Project description:RNAseq data from healthy feline tissues

| PRJNA882763 | ENA